Director Diane Jorkasky bought 527 ALT shares at $3.80; cluster pattern: 2 other insiders bought within 14 days
Diane Jorkasky, a director, purchased 527 shares of Altimmune at $3.80 on 2025-12-29, initiating a new position from zero prior holdings. This purchase is part of a cluster buy pattern, with 2 other insiders also acquiring shares within the past 14 days, suggesting coordinated or contemporaneous interest in the stock despite challenging fundamentals. The company reported revenue of $5,000.00 in its latest quarter and net income of $-19,014,000.00 over its most recent full fiscal year, with annual revenue declining 95.3% year-over-year, indicating severe operational distress. The stock is trading 54.0% below its 52-week high and has declined 30.0% over the past 30 days, providing context for insider purchases at a depressed price level relative to recent history.